• SARS-CoV-2 (Coronavirus), Antigen Test
  • Low Density Lipoprotein Receptor (LDLR) Gene Mutation Analysis
  • Isoniazid, Serum
  • COL1A1/COL1A2 Genes Variations Analysis
  • Minimal Residual Disease (MRD) for Early Detection of Cancer Recurrence (Signatera™, Haystack MRD™)
  • Halazepam, Urine
  • Coagulation Factor II Inhibitor Assay, Plasma
  • Ehlers-Danlos Syndrome Gene Mutation Panel, NGS
  • Nomogram, Gastric Cancer
  • Bartonella Antibody, IgG and IgM, CSF
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Low Density Lipoprotein Receptor (LDLR) Gene Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Low Density Lipoprotein Receptor (LDLR) Gene Mutation Analysis
Medical Test

LOINC
Access to Low Density Lipoprotein Receptor (LDLR) Gene Mutation Analysis is restricted.
Loading...